Science Explorer Interactive view Map
Company · Warsaw · Poland

OncoArendi Therapeutics (Poland)

Research works
24
▲ 74% vs 2013–17
Citations
250
10.3 per fractional work
Top-10% rate
8.4%
record average 16.5%
Open access
70%
world 28%

Not ranked overall: OncoArendi Therapeutics (Poland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 2.30× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.27× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 3.10× its world share, 0 worksImmunology and Micro…Computer Science: 2.01× its world share, 1 worksComputer ScienceEarth and Planetary Sciences: 1.99× its world share, 0 worksEarth and Planetary …Engineering: 0.42× its world share, 0 worksEngineeringMedicine: 1.02× its world share, 1 worksMedicineBusiness, Management and Accounting: 5.81× its world share, 1 worksBusiness, Management…world share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Business, Management and Accounting, 5.8×. Every wedge is a field page.

Which keywords describe research at OncoArendi Therapeutics (Poland)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Metabolism, Immune Response, Asthma, Regulation, Biomarkers, Chitin and Enzymes.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 25 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 25 words, with their numbers
  1. Inflammation5▲ 8.2×5 topics
  2. Metabolism4▲ 27×3 topics
  3. Immune Response4▲ 25×2 topics
  4. Asthma4▲ 115×3 topics
  5. Regulation3▲ 22×3 topics
  6. Biomarkers3▲ 21×3 topics
  7. Chitin3▲ 358×1 topic
  8. Enzymes3▲ 321×1 topic
  9. Cancer2▲ 5.0×6 topics
  10. Immunotherapy2▲ 10×4 topics
  11. Geotechnical Engineering1▲ 103×2 topics
  12. Tumor Targeting1▲ 41×2 topics
  13. Activation1▲ 123×1 topic
  14. Gene Therapy1▲ 17×2 topics
  15. Immunity1▲ 14×2 topics
  16. Macrophage1▲ 76×1 topic
  17. Supply Chain Management1▲ 8.9×2 topics
  18. Tumor Regression1▲ 52×2 topics
  19. Arginine Deprivation1▲ 96×1 topic
  20. Bacterial Therapy1▲ 96×1 topic
  21. Incoterms1▲ 229×1 topic
  22. Letters of Credit1▲ 229×1 topic
  23. Material Properties1▲ 32×2 topics
  24. Structural Health Monitoring1▲ 40×2 topics
  25. Tumor Microenvironment1▲ 12×2 topics

Which research topics does OncoArendi Therapeutics (Poland) publish most on?

By volume in 2022–2025: Law, logistics, and international trade, Studies on Chitinases and Chitosanases, Pineapple and bromelain studies and Inhalation and Respiratory Drug Delivery.

  1. 1 Law, logistics, and international trade Accounting 1 works
  2. 2 Studies on Chitinases and Chitosanases Molecular Biology 0 works
  3. 3 Pineapple and bromelain studies Molecular Biology 0 works
  4. 4 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 0 works
  5. 5 Ethnobotanical and Medicinal Plants Studies Plant Science 0 works
  6. 6 Asthma and respiratory diseases Physiology 0 works
  7. 7 Advanced Software Engineering Methodologies Artificial Intelligence 0 works
  8. 8 Service-Oriented Architecture and Web Services Information Systems 0 works
  9. 9 Protease and Inhibitor Mechanisms Cancer Research 0 works
  10. 10 Distributed systems and fault tolerance Computer Networks and Communications 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available69.9%not open30.1%

World: 28% of research is openly available.

with international co-authors19.6%domestic only80.4%

World: 19% is written across borders.

How has OncoArendi Therapeutics (Poland)'s research output changed?

Output in 2018–2022 was 74% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Warsaw

All research institutions in Warsaw

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.